Palliative Care Still Underutilized in Hematologic Malignancies

Data from an abstract presented at the 2019 Supportive Care in Oncology Symposium demonstrated that patients with hematologic malignancies, including MPNs, who received late palliative care or none at all spent a median nine days in hospice, versus 22 days among patients who received early palliative care.